1. Home
  2. Analysis
  3. Soy
  4. Anoro-ellipta

Soy and Anoro ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soy (soy) and Anoro ellipta (umeclidinium bromide; vilanterol trifenatate). Common drug interactions include neuralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Soy and Anoro ellipta. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Soy?

Soy has active ingredients of soy. eHealthMe is studying from 562 Soy users. Check the latest studies of Soy.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

On Jul, 26, 2026

20 people who take Soy and Anoro ellipta together, and have interactions are studied.

Soy and Anoro ellipta drug interactions.

What are the common drug interactions of Soy and Anoro Ellipta, by gender? *:

female:

n/a

male:

  1. Neuralgia (pain in one or more nerves)
  2. Drug hypersensitivity
  3. Abdominal pain
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Activated partial thromboplastin time prolonged
  6. Drug intolerance (drug sensitivity)
  7. Dry mouth
  8. Abdominal distension
  9. Appendicitis (inflammation of the appendix)
  10. Ascites (accumulation of fluid in the abdominal cavity)

What are the common drug interactions of Soy and Anoro Ellipta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Neuralgia (pain in one or more nerves)
  2. Drug hypersensitivity
  3. Abdominal pain
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Activated partial thromboplastin time prolonged
  6. Drug intolerance (drug sensitivity)
  7. Dry mouth
  8. Abdominal distension
  9. Appendicitis (inflammation of the appendix)
  10. Ascites (accumulation of fluid in the abdominal cavity)

What are the existing conditions these people have? *

  1. Anaemia (lack of blood): 20 people, 100.00%
  2. Iron Deficiency: 20 people, 100.00%
  3. Constipation: 20 people, 100.00%
  4. Diabetes: 20 people, 100.00%
  5. Blood Uric Acid Increased: 20 people, 100.00%
  6. Dyspnea (difficult or laboured breathing): 20 people, 100.00%
  7. High Blood Cholesterol: 20 people, 100.00%
  8. Ventricular Fibrillation (abnormally irregular heart rhythm): 20 people, 100.00%
  9. Blood Phosphorus Increased: 20 people, 100.00%
  10. Nausea (feeling of having an urge to vomit): 20 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Soy and Anoro ellipta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Soy and Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Soy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anoro ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on soy and umeclidinium bromide; vilanterol trifenatate (the active ingredients of Soy and Anoro ellipta, respectively), and Soy and Anoro ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.